Sign in

CIK 0001176309 · Non-accelerated filer<br>Smaller reporting company

ORAMED PHARMACEUTICALS INC.

Sign in to watch
Ticker
ORMP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
980376008
Phone
646-844-1164
Business address
1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY, 10036
Former names
Integrated Security Technologies, Inc., IGUANA VENTURES LTD
  1. 4 Grant or award Chief Scientific Officer acquired 295,500 shares (grant or award)
  2. 4 Grant or award President and CEO acquired 329,000 shares (grant or award)
  3. 4 Grant or award COO & CBO acquired 180,500 shares (grant or award)
  4. 4 Grant or award Chief Financial Officer acquired 136,500 shares (grant or award)
  5. 4 Grant or award Director acquired 39,325 shares (grant or award)
  6. 4 Grant or award Director acquired 38,820 shares (grant or award)
  7. 4 Grant or award Director acquired 39,325 shares (grant or award)
  8. 4 Grant or award Director acquired 35,070 shares (grant or award)
  9. 4 Grant or award Director acquired 35,070 shares (grant or award)
  10. 3 Insider Initial Statement of Ownership
  11. 4 Grant or award President and CEO acquired 120,000 shares (grant or award)
  12. 4 Grant or award Chief Scientific Officer acquired 53,500 shares (grant or award)
  13. 4 Grant or award Chief Legal Officer acquired 20,500 shares (grant or award)
  14. 4 Grant or award COO & CBO acquired 27,000 shares (grant or award)
  15. 4 Grant or award Chief Financial Officer acquired 24,500 shares (grant or award)
  16. 4 Grant or award Director acquired 20,000 shares (grant or award)
  17. 3 Insider Initial Statement of Ownership
  18. 4 Grant or award Director acquired 30,000 shares (grant or award)
  19. 4 Grant or award Chief Legal Officer acquired 81,000 shares (grant or award)
  20. 4 Grant or award COO & CBO acquired 108,000 shares (grant or award)

Page 4 of 16 · 306 filings